Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
54 studies found for:    Open Studies | "Testicular Neoplasms"
Show Display Options
Rank Status Study
1 Recruiting Swiss Austrian German Testicular Cancer Cohort Study - SAG TCCS
Condition: Testicular Neoplasms
Intervention:
2 Recruiting Testicular Cancer and Aerobic and Strength Training
Condition: Testicular Neoplasms
Interventions: Behavioral: Exercise group;   Behavioral: Control group
3 Recruiting Quality of Life Among Testicular Cancer Survivors
Conditions: Testicular Neoplasms;   Spermatic Cord Torsion;   Varicocele;   Testicular Hydrocele
Interventions: Other: Questionnaires;   Other: Hormonal Function measurement
4 Recruiting Adjuvant Bleomycin, Etoposide and Cisplatin (BEP) Versus Carboplatin in Stage I Seminomatous Testicular Cancer
Conditions: Testicular Neoplasms;   Seminoma
Interventions: Drug: Bleomycin Etoposide and Cisplatin;   Drug: Carboplatin
5 Recruiting Cause of Familial Testicular Cancer
Condition: Testicular Cancer
Intervention:
6 Recruiting Shared Care Follow-up After Chemotherapy for Testicular Cancer
Condition: Testicular Cancer
Intervention:
7 Recruiting Health Status and Burden of Late Effects in Very Long-term Testicular Cancer Survivors (STANDBY-study)
Condition: Testicular Cancer
Intervention:
8 Recruiting Germ Cell Tumor and Testicular Tumor DNA Registry
Conditions: Germ Cell Tumor;   Testicular Tumor
Interventions: Behavioral: Questionnaires;   Other: sample of blood or saliva
9 Recruiting The Platinum Study Comparison Group
Condition: Testicular Neoplasms
Intervention: Behavioral: Questionnaire
10 Recruiting Study of Gemcitabine, Carboplatin and VELIPARIB (ABT-888) in Refractory Testicular Germ Cell Cancer
Condition: Testicular Cancer
Interventions: Drug: Veliparib;   Drug: Gemcitabine;   Drug: Carboplatin
11 Recruiting Establishing of Neuronal-like Cells From Patients With Cisplatin-Induced Peripheral Neuropathy
Conditions: Peripheral Nervous System Diseases;   Testicular Neoplasms
Interventions: Procedure: Blood sample collection;   Behavioral: Report of peripheral neuropathy after cisplatin therapy
12 Recruiting TACkLE Study - Tackling Adverse Chemotherapy-associated Late Effects
Condition: Testicular Cancer
Intervention: Other: Vena punction
13 Recruiting Defining the Genetic Basis for the Development of Primary Pigmented Nodular Adrenocortical Disease (PPNAD) and the Carney Complex
Conditions: Cushing's Syndrome;   Hereditary Neoplastic Syndrome;   Lentigo;   Neoplasm;   Testicular Neoplasm
Intervention:
14 Not yet recruiting MED-C Registry: Advanced Malignancy or Myelodysplasia, Tested by Standard Sequencing and Treated by Physician Choice
Conditions: Neoplasms;   Lung Neoplasms;   Colon Neoplasms;   Breast Neoplasms;   Pancreatic Neoplasms;   Prostate Neoplasms;   Kidney Neoplasms;   Liver Neoplasms;   Rectal Neoplasms;   Hematologic Neoplasms;   Multiple Myeloma;   Myelodysplastic Syndromes;   Ovarian Neoplasms;   Bladder Neoplasms;   Testicular Neoplasms;   Endometrial Neoplasms;   Brain Neoplasms;   Biliary Tract Neoplasms;   Head and Neck Neoplasms;   Uterine Cervical Neoplasms;   Skin Neoplasms;   Melanoma;   Gastric Neoplasms;   Anal Neoplasms;   Sarcoma
Intervention: Other: Provider determined
15 Recruiting Pembrolizumab in Subjects With Incurable Platinum-Refractory Germ Cell Tumors
Conditions: Germ Cell Neoplasms;   Testicular Neoplasms;   Non Seminomatous Germ Cell Tumors;   Mediastinal Neoplasms;   Genital Neoplasms, Male;   Genital Neoplasms, Female;   Ovarian Neoplasms
Intervention: Drug: Pembrolizumab
16 Not yet recruiting Vascular Fingerprint Validation Study
Condition: Testicular Cancer
Intervention:
17 Recruiting PHASE II TRIAL OF THE CYCLIN-DEPEDENT KINASE INHIBITOR PD 0332991 IN PATIENTS WITH CANCER
Conditions: Adult Solid Tumor;   Adenocarcinoma of the Colon;   Adenocarcinoma of the Rectum;   Adult Central Nervous System Germ Cell Tumor;   Adult Teratoma;   Benign Teratoma;   Estrogen Receptor-negative Breast Cancer;   Estrogen Receptor-positive Breast Cancer;   Familial Testicular Germ Cell Tumor;   HER2-negative Breast Cancer;   HER2-positive Breast Cancer;   Male Breast Cancer;   Ovarian Immature Teratoma;   Ovarian Mature Teratoma;   Ovarian Monodermal and Highly Specialized Teratoma;   Progesterone Receptor-negative Breast Cancer;   Progesterone Receptor-positive Breast Cancer;   Recurrent Breast Cancer;   Recurrent Colon Cancer;   Recurrent Extragonadal Germ Cell Tumor;   Recurrent Extragonadal Non-seminomatous Germ Cell Tumor;   Recurrent Extragonadal Seminoma;   Recurrent Malignant Testicular Germ Cell Tumor;   Recurrent Melanoma;   Recurrent Ovarian Germ Cell Tumor;   Recurrent Rectal Cancer;   Stage III Extragonadal Non-seminomatous Germ Cell Tumor;   Stage III Extragonadal Seminoma;   Stage III Malignant Testicular Germ Cell Tumor;   Stage III Ovarian Germ Cell Tumor;   Stage IV Breast Cancer;   Stage IV Colon Cancer;   Stage IV Extragonadal Non-seminomatous Germ Cell Tumor;   Stage IV Extragonadal Seminoma;   Stage IV Melanoma;   Stage IV Ovarian Germ Cell Tumor;   Stage IV Rectal Cancer;   Testicular Immature Teratoma;   Testicular Mature Teratoma
Interventions: Drug: PD-0332991;   Other: pharmacological study
18 Recruiting Testis CAB: Cabazitaxel as Salvage Treatment for Cisplatin-resistant Germ Cell Cancer
Condition: Testicular Cancer
Intervention: Drug: cabazitaxel
19 Unknown  Sorafenib Monotherapy in Inoperable/Recurrent Germ Cell Carcinoma Refractory to Chemotherapy
Condition: Testicular Cancer
Intervention: Drug: sorafenib
20 Recruiting High-dose Chemotherapy for Poor-Prognosis Relapsed Germ-Cell Tumors
Condition: Testicular Cancer
Interventions: Drug: Gemcitabine;   Drug: Docetaxel;   Drug: Melphalan;   Drug: Carboplatin;   Drug: Mesna;   Drug: Ifosfamide;   Drug: Etoposide;   Procedure: Stem Cell Transplant

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years